Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 12, 2025 • 12:00 PM ET

Date/Time Source News Release
01/30/2023 04:51 PM EST Newsfile CSE Bulletin: Name and Symbol Change - Nurosene Health Inc. (MEND)
01/30/2023 08:30 AM EST Canada Newswire INTRODUCING NETRAMARK - A PHARMA AI COMPANY
01/18/2023 05:45 AM EST Canada Newswire NUROSENE ANNOUNCES ADVISORY ROLE WITH RARE-X
12/06/2022 08:45 AM EST Canada Newswire NUROSENE CHIEF SCIENCE OFFICER PRESENTS AT LEADING DRUG DEVELOPMENT FORUM
12/01/2022 04:05 PM EST Canada Newswire NUROSENE BUSINESS UPDATE
10/31/2022 05:30 PM EDT Canada Newswire NUROSENE HEALTH INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT
10/14/2022 03:14 PM EDT Canada Newswire NUROSENE HEALTH INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT
08/24/2022 09:00 AM EDT Canada Newswire NUROSENE APPOINTS NEUROSURGEON DR. DOUGLAS JAMES COOK AS CHIEF MEDICAL OFFICER
08/23/2022 09:15 AM EDT Canada Newswire Nurosene Appoints New Advisory Board Member Dhananja Jayalath
07/22/2022 08:00 AM EDT Canada Newswire NUROSENE APPOINTS INDUSTRY VETERAN DR. LUCA PANI AS CHIEF INNOVATION AND REGULATORY OFFICER
Page

Additional News

As of April 12, 2025 • 12:00 PM ET

Date/Time Source News Release
06/11/2021 09:40 AM EDT InvestorIdeas.com New Stocks to Watch at Investor Ideas in Mining (CSE: OZ) (TSXV: ELE), Cannabis (CSE: REZN), Crypto (OTC: KYNC) and Health & Wellness (CSE: MEND)
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.